期刊文献+

Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy 被引量:21

下载PDF
导出
摘要 Background Serum cystatin C levels can be used to predict morbidity and mortality in patients with cardiovascular disease. However, the clinical relevance of serum cystatin C levels in patients with hypertensive left ventricular hypertrophy (LVH) has rarely been investigated. We designed the present study to investigate whether serum cystatin C levels are associated with cardiac structural and functional alterations in hypertensive patients. Methods We enrolled 823 hypertensive patients and classified them into two groups:those with LVH (n=287) and those without LVH (n=536). All patients underwent echocardiography and serum cystatin C testing. We analyzed the relationship be-tween serum cystatin C levels and LVH. Results Serum cystatin C levels were higher in hypertensive patients with LVH than in those without LVH (P<0.05). Using linear correlation analysis, we found a positive correlation between serum cystatin C levels and interven-tricular septal thickness (r=0.247, P<0.01), posterior wall thickness (r=0.216, P<0.01), and left ventricular weight index (r=0.347, P<0.01). When analyzed by multiple linear regression, the positive correlations remained between serum cystatin C and interventricular septal thickness (β=0.167, P<0.05), posterior wall thickness (β=0.187, P<0.05), and left ventricular weight index (β=0.245, P<0.01). Con-clusion Serum cystatin C concentration is an independent marker for hypertensive LVH.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2013年第3期286-290,共5页 老年心脏病学杂志(英文版)
  • 相关文献

参考文献28

  • 1Aumann N,Baumeister SE,Werner A. Inverse associa-tion of estimated cystatin C-and creatinine-based glomerular filtration rate with left ventricular mass:Results from the Study of Health in Pomerania[J].International Journal of Cardiology,2013.2786-2791.
  • 2Mathew J,Katz R,St John Sutton M. Chronic kidney disease and cardiac remodelling in patients with mild heart failure:results from the REsynchronization reVErses Remod-eling in Systolic Left vEntricular Dysfunction (REVERSE) study[J].European Journal of Heart Failure,2012.1420-1428.
  • 3Park M,Hsu CY,Li Y. Associations between kidney function and subclinical cardiac abnormalities in CKD. Chronic Renal Insufficiency Cohort (CRIC) Study Group[J].Journal of the American Society of Nephrology,2012.1725-1734.
  • 4Kilic T,Oner G,Ural E. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function,markers of inflammation and systolic dysfunction among patients with acute coronary syndrome[J].Atherosclero-sis,2009.552-558.
  • 5Shin MJ,Song SH,Kwak IS. Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis[J].Clinical and Experimental Nephrology,2012.456-463.
  • 6Pérez-Calvo JI,Ruiz-Ruiz FJ,Carrasco-Sánchez FJ. Prognostic value of serum cystatin C and N-terminal pro b-type natriuretic peptide in patients with acute heart failure[J].European Journal of Internal Medicine,2012.599-603.
  • 7Monteiro Junior Fd,Ferreira PA,Nunes JA. Correlation between serum cystatin C and markers of subclinical athero-sclerosis in hypertensive patients[J].Arquivos Brasileiros de Cardiologia,2012.899-906.
  • 8Dupont M,Wu Y,Hazen SL. Cystatin C identifies pa-tients with stable chronic heart failure at increased risk for adverse cardiovascular events[J].Circ Heart Fail,2012.602-609.
  • 9Prats M,Font R,Bardají A. Cystatin C and cardiac hy-pertrophy in primary hypertension[J].Blood Pressure,2010.20-25.
  • 10Tousoulis D,Androulakis E,Papageorgiou N. Genetic predisposition to left ventricular hypertrophy and the potential involvement of cystatin-C in untreated hypertension[J].American Journal of Hypertension,2013.683-690.

同被引文献103

引证文献21

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部